Answer
Combining Otrivine Extra Dual Relief nasal spray with beta-2 agonists may increase the risk of acute glaucoma in patients with a history of angle-closure glaucoma because it contains ipratropium.
Sources for this answer
- Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solutionHaleon Dungarvan · emc · SmPC §4.5 Interaction with other medicinal products · Version 7Document updated
Sources checked